US EditionMiddle East war disrupts pharma air routes, risks cancer drugs supply
Over 20% of global air cargo for temperature-sensitive medicines faces disruption, risking shortages of critical cancer drugs if rerouting challenges persist, experts warn.
- War in the Middle East is disrupting temperature-sensitive medicine shipments to the Gulf, forcing carriers to reroute flights and use overland transport.
- Major air transit hubs including Dubai, Abu Dhabi, and Doha have been closed recently, snarling goods movement after the conflict sparked by U.S. and Israeli attacks on Iran.
- Secondary supply chain snags, such as shortages of vial stoppers, said David Weeks, who follows the supply chain industry for ratings agency Moody’s.
- Prashant Yadav of the Council warned stocks of short shelf-life medicines could be depleted within four to six weeks, risking treatment delays for patients.
- Over 100 participants joined a Pharma and Aero webinar last week, and while the industry is coping for now, executives warn cold-chain corridors are not easily established.
19 Articles
19 Articles
China–Middle East Air Cargo Recovers as Routes Shift North From Gulf Hubs
China–Middle East Air Cargo Recovers as Routes Shift North From Gulf Hubs - Conflict-linked airspace closures are reshaping regional freight networks, diverting traffic to Turkey, Azerbaijan and Saudi Arabia while pushing rates higher
Middle East war disrupting pharma air routes
War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and forcing companies to reroute flights and find overland access into the region, industry executives said.
Middle East war disrupts pharma air routes, risks cancer drugs supply
War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration and forcing companies to reroute flights and find overland access into the region, industry executives said.
Coverage Details
Bias Distribution
- 42% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
